P3H2 and central nervous system cancer: In contrast, we found no evidence for methylation of P3H2 in analysis of cell lines from multiple other tumour types, including ovarian and renal adenocarcinomas, squamous carcinomas of the vulva and head and neck, malignant melanoma and glioma (Figure 1D; data not shown).